1News 1News — your global news briefing, coming soon on iOS & Android
Coming Soon
1News 1News
Top Business Entertainment Sports Technology Politics Science Lifestyle
Back to Business
AstraZeneca reports Ultomiris meets primary endpoint in IgAN Phase III trial
Business April 21, 2026 at 10:22 AM

AstraZeneca reports Ultomiris meets primary endpoint in IgAN Phase III trial

Investing.com
Read at Investing.com
More Stories
S&P 500 Futures Rally as Traders Await Updates on Iran, Warsh
Business
S&P 500 Futures Rally as Traders Await Updates on Iran, Warsh

US stock-index futures rose before the bell on Tuesday as traders awaited developments on Iran and Kevin Warsh’s Senate …

🇺🇸 Bloomberg Markets 44m ago
Lenz Therapeutics stock price target cut to $48 by H.C. Wainwright
Business
Lenz Therapeutics stock price target cut to $48 by H.C. Wainwright
🇺🇸 Investing.com 49m ago
Top Software Stocks Positioned for AI Security Boom According to Morgan Stanley
Business
Top Software Stocks Positioned for AI Security Boom According to Morgan Stanley
🇺🇸 Investing.com 49m ago
1News
Your world briefing, in your pocket

AI-curated news from 12 countries and 10 languages — coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play
1News 1News

Your global news briefing — 300+ sources, 12 countries, 10 languages.

Support 1News Settings Search AI Info

© 2026 1News. The world's news, curated for you.